Supramolecular chemistry

Global Inorganic Catalyst Industry Report 2023-2024 & 2028: Paving the Way to Cleaner Energy with Government Backing

Retrieved on: 
Friday, August 18, 2023
Population growth, Urbanization, Jaume I University, Plastic, University, Catalysis, Metal, Zeolite, Hydrogen, Electronics, Aluminium, Magnesium, Hydrogenation, Gasoline, Electricity, Platinum, Polymerization, Polymer, Carbonate, Carbon, Palladium, Government, Titanium, Wind, Competition, Solvent, Climate change, Application, Supramolecular chemistry, Growth, Polyethylene, Polyvinyl chloride, CO2, Benzene, Ziegler–Natta catalyst, Rhodium, Chemical, Renewable energy

The key drivers of the global inorganic catalyst market are the increasing demand for clean and efficient energy sources.

Key Points: 
  • The key drivers of the global inorganic catalyst market are the increasing demand for clean and efficient energy sources.
  • Inorganic catalysts play a critical role in the production of clean energy sources such as hydrogen, biodiesel, and bioethanol.
  • Another major driver of the global inorganic catalyst market is the growing demand for petrochemicals and polymers.
  • Moreover, to their use in clean energy production, inorganic catalysts are also being used to improve the efficiency of energy production from fossil fuels.

Pivot Bio Raises $430 Million to Replace Synthetic Fertilizers in Agriculture

Retrieved on: 
Monday, July 19, 2021
Chemistry, Physical sciences, Natural sciences, Dynamic covalent chemistry, Organic chemistry, Supramolecular chemistry, Nitrogen

Pivot Bio's clean nitrogen immediately decreases and permanently prevents synthetic nitrogen emissions from the environment, potentially avoiding approximately $200 billion of environmental impact.

Key Points: 
  • Pivot Bio's clean nitrogen immediately decreases and permanently prevents synthetic nitrogen emissions from the environment, potentially avoiding approximately $200 billion of environmental impact.
  • Pivot Bio's next stage of growth will focus on rapidly scaling its U.S. business and expanding into key international markets.
  • Pivot Bio has delivered the kind of win-win-win breakthrough DCVC is honored to back, and on which we are focused as a firm."
  • Pivot Bio PROVEN 40, the company's fourth commercial product in three years, enables farmers to replace up to 40 pounds per acre of synthetic nitrogen, almost double the performance of Pivot Bio's inaugural product.

Kanazawa University research: Solvent effects of siloxanes on donor-acceptor interactions

Retrieved on: 
Tuesday, May 11, 2021
Physical sciences, Natural sciences, Chemistry, Supramolecular chemistry, Chemical bonding, Non-covalent interaction, Supramolecular polymer, Pi interaction

b'KANAZAWA, Japan, May 11, 2021 /PRNewswire/ -- Researchers at Kanazawa University report in Chemical Communications how solvents influence the strength of donoracceptor interactions.

Key Points: 
  • b'KANAZAWA, Japan, May 11, 2021 /PRNewswire/ -- Researchers at Kanazawa University report in Chemical Communications how solvents influence the strength of donoracceptor interactions.
  • The aromatic DA interactions are widely used for building supramolecular structures, which are assembly of molecules formed by non-covalent bonds like building blocks.
  • The stability and smart properties of supramolecular architectures formed by D-A interactions depend on characteristics of the DA interactions in various circumstances.
  • Poly(dimethylsiloxane) and oligo(dimethylsiloxane) solvent effects on aromatic donoracceptor interactions, Chem.

Kanazawa University research: Solvent effects of siloxanes on donor-acceptor interactions

Retrieved on: 
Tuesday, May 11, 2021
Physical sciences, Natural sciences, Chemistry, Supramolecular chemistry, Chemical bonding, Non-covalent interaction, Supramolecular polymer, Pi interaction

b'KANAZAWA, Japan, May 11, 2021 /PRNewswire/ -- Researchers at Kanazawa University report in Chemical Communications how solvents influence the strength of donoracceptor interactions.

Key Points: 
  • b'KANAZAWA, Japan, May 11, 2021 /PRNewswire/ -- Researchers at Kanazawa University report in Chemical Communications how solvents influence the strength of donoracceptor interactions.
  • The aromatic DA interactions are widely used for building supramolecular structures, which are assembly of molecules formed by non-covalent bonds like building blocks.
  • The stability and smart properties of supramolecular architectures formed by D-A interactions depend on characteristics of the DA interactions in various circumstances.
  • Poly(dimethylsiloxane) and oligo(dimethylsiloxane) solvent effects on aromatic donoracceptor interactions, Chem.

Unlearn.AI Announces Series A Extension with New Investment from Epic Ventures, Alumni Ventures Group, and Global Pharma Company Eisai

Retrieved on: 
Thursday, November 5, 2020
Health, Technology, Genetics, Software, Clinical trials, Pharmaceutical, Biotechnology, Branches of science, Articles, Science and technology, Dynamic covalent chemistry, Organic chemistry, Supramolecular chemistry, Artificial intelligence, Digital twin, Health, Technology, Genetics, Software, Clinical trials, Pharmaceutical, Biotechnology, Branches of science, Articles, Science and technology, Dynamic covalent chemistry, Organic chemistry, Supramolecular chemistry, Artificial intelligence, Digital twin

In April 2020, Unlearn announced Series A financing led by 8VC with participation from DCVC, DCVC Bio and Mubadala Capital Ventures.

Key Points: 
  • In April 2020, Unlearn announced Series A financing led by 8VC with participation from DCVC, DCVC Bio and Mubadala Capital Ventures.
  • The extension brings the Series A total to $15 million.
  • Unlearn has proven how generative AI-models trained on clinical data can be successfully utilized to create Digital Twins of patients for complex populations such as Alzheimers Disease.
  • Unlearn has developed a proprietary AI-model used to generate Digital Twins that are statistically indistinguishable from actual Alzheimers Disease patient data.

Ashvattha Therapeutics Announces Formation of Scientific Advisory Board

Retrieved on: 
Thursday, October 29, 2020
Health, Genetics, Other Health, General Health, Clinical trials, Pharmaceutical, Biotechnology, Dendrimer, Supramolecular chemistry

Ashvattha Therapeutics , a clinical-stage biotech company focused on novel hydroxyl dendrimer therapeutics (HDTs) targeted to reactive inflammatory cells, to treat unmet medical needs in oncology, ocular, and inflammatory diseases, today announced the formation of a Scientific Advisory Board (SAB), chaired by Kannan Rangaramanujam, Ph.D, founder and Chief Technology Officer.

Key Points: 
  • Ashvattha Therapeutics , a clinical-stage biotech company focused on novel hydroxyl dendrimer therapeutics (HDTs) targeted to reactive inflammatory cells, to treat unmet medical needs in oncology, ocular, and inflammatory diseases, today announced the formation of a Scientific Advisory Board (SAB), chaired by Kannan Rangaramanujam, Ph.D, founder and Chief Technology Officer.
  • The scientific guidance of this group of experts will be invaluable as we translate HDTs to the clinic to help patients, said Jeffrey Cleland, Ph.D., Chairman, CEO & President at Ashvattha Therapeutics.
  • The members of Ashvattha Therapeutics Scientific Advisory Board include:
    Kannan Rangaramanujam, Ph.D., (Chair) the Arnall Patz distinguished professor of ophthalmology and co-director of center for nanomedicine at the Wilmer Eye Institute at Johns Hopkins School of Medicine.
  • Ashvattha Therapeutics, a clinical stage biopharmaceutical company, is developing novel therapeutics that target and alter reactive inflammatory cells localized in the diseased tissues.

TALLC Corporation Announces Grant of New SmartCelle Patent for Enhanced Ocular Delivery of TA-A001

Retrieved on: 
Tuesday, July 7, 2020
Colloidal chemistry, Membrane biology, Micelle, Supramolecular chemistry, Drug

GB2561009 covers the chemical composition of SmartCelle polymers, their method of manufacture and their ability to form 20nm-30nm stable drug-loaded dynamic micelles in aqueous solution.

Key Points: 
  • GB2561009 covers the chemical composition of SmartCelle polymers, their method of manufacture and their ability to form 20nm-30nm stable drug-loaded dynamic micelles in aqueous solution.
  • "This first SmartCelle patent is an invaluable addition to our growing patent portfolio, and we expect it to issue in North America shortly," said Damon Smith CEO of TALLC.
  • We believe that our full CB2 agonist TA-A001, enabled by SmartCelle technology, can improve the lives of patients suffering these debilitating diseases".
  • Delivery of TALLC drug candidates topically, by injection or by inhalation, is enabled by SmartCelle micelles.

Farm Shield Launches New Tech to Enhance Crop Protection

Retrieved on: 
Thursday, June 18, 2020
Technology, Nanotechnology, Agriculture, Natural Resources, Agronomy, Applied sciences, Articles, Chemistry, Supramolecular chemistry, Crop protection, Agriculture, Shield

Farm Shield has emerged from stealth mode to address the needs of crop protection companies with their proprietary platform technology.

Key Points: 
  • Farm Shield has emerged from stealth mode to address the needs of crop protection companies with their proprietary platform technology.
  • Farm Shields unique supramolecular host chemistry can broadly improve crop protection product performance and lower use rates, leading to an eco-friendly solution to safeguard crops globally.
  • David Coorts, technical director at Farm Shield, shared: This is a unique approach to improve the many existing crop protection products already on the market.
  • Farm Shield is a Texas-based agricultural innovation company, utilizing a proprietary aqueous-based supramolecular host chemistry to enhance efficacy of crop protection formulas.

Effepharm Announced Acquisitions and New R&D Center Establishment

Retrieved on: 
Thursday, December 12, 2019
Dendrimer, Supramolecular chemistry

Dr. Jianjun Yu and Dr. Jian Hu, together with their teams came from global leading pharmaceutical firms, joined Effepharm.

Key Points: 
  • Dr. Jianjun Yu and Dr. Jian Hu, together with their teams came from global leading pharmaceutical firms, joined Effepharm.
  • The group of R&D professionals are dedicated to contribute their skills and talents to Effepharm.
  • Dr. Yu, former GSK scientist and now R&D Director of Effepharm, talked about how this corporation brings values to Effepharm, Dendrimer and Folvo.
  • Effepharm is one of the major dietary ingredients manufacturers and distributors in China with customers mainly from US & EU etc.

Effepharm Announced Acquisitions and New R&D Center Establishment

Retrieved on: 
Thursday, December 12, 2019
Biotechnology, Pharmaceutical, Fitness & Nutrition, Health, Dendrimer, Supramolecular chemistry

Dr. Jianjun Yu and Dr. Jian Hu, together with their teams came from global leading pharmaceutical firms, joined Effepharm.

Key Points: 
  • Dr. Jianjun Yu and Dr. Jian Hu, together with their teams came from global leading pharmaceutical firms, joined Effepharm.
  • The group of R&D professionals are dedicated to contribute their skills and talents to Effepharm.
  • Dr. Yu, former GSK scientist and now R&D Director of Effepharm, talked about how this corporation brings values to Effepharm, Dendrimer and Folvo.
  • Effepharm is one of the major dietary ingredients manufacturers and distributors in China with customers mainly from US & EU etc.